CD4-话题@MedSci

#CD4#

117篇内容 | 3228人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1864287, encodeId=fb3f186428e5f, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Blood：HCT后CD4+T细胞重建可预测急性GvHD患者的存活预后, objectType=article, longId=203527, objectId=c4e320352ed3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4e320352ed3, replyNumber=0, likeNumber=77, createdTime=2021-08-24, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4e320352ed3, moduleTitle=Blood：HCT后CD4+T细胞重建可预测急性GvHD患者的存活预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4e320352ed3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864285, encodeId=427b186428504, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Int Arch Allergy Immunol：间歇性过敏性鼻炎患者的血清CD48水平的提高 , objectType=article, longId=202565, objectId=512b202565e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=512b202565e0, replyNumber=0, likeNumber=51, createdTime=2021-01-09, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=512b202565e0, moduleTitle=Int Arch Allergy Immunol：间歇性过敏性鼻炎患者的血清CD48水平的提高 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=512b202565e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864297, encodeId=85b5186429e2b, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=宜明昂科CD47xHER2双特异性抗体获批临床，适应症为HER2表达的晚期实体瘤, objectType=article, longId=213747, objectId=dec0213e4729, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dec0213e4729, replyNumber=0, likeNumber=65, createdTime=2022-04-03, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dec0213e4729, moduleTitle=宜明昂科CD47xHER2双特异性抗体获批临床，适应症为HER2表达的晚期实体瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dec0213e4729)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864280, encodeId=c1551864280b3, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=高瓴牵头砸进4亿美金，加持天境生物联手艾伯维开发明星靶点CD47, objectType=article, longId=200312, objectId=3baf200312d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3baf200312d2, replyNumber=0, likeNumber=64, createdTime=2021-03-07, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3baf200312d2, moduleTitle=高瓴牵头砸进4亿美金，加持天境生物联手艾伯维开发明星靶点CD47, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3baf200312d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864293, encodeId=0315186429303, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=思路迪医药获新一代CD47抗体新药大中华区**授权, objectType=article, longId=209469, objectId=aa2920946911, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa2920946911, replyNumber=0, likeNumber=0, createdTime=2021-06-29, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa2920946911, moduleTitle=思路迪医药获新一代CD47抗体新药大中华区**授权, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa2920946911)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864286, encodeId=11771864286b2, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=DCR：CD4/CD8比值可以作为HIV 阳性患者高级别肛门异型增生和肛门癌风险的新标志物, objectType=article, longId=203218, objectId=67192032182b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67192032182b, replyNumber=0, likeNumber=73, createdTime=2021-09-13, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67192032182b, moduleTitle=DCR：CD4/CD8比值可以作为HIV 阳性患者高级别肛门异型增生和肛门癌风险的新标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67192032182b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864283, encodeId=7386186428311, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Innate Immun：CD40上调树突状细胞与Th17/Treg失衡从而促进年轻人慢性牙周炎的骨丧失, objectType=article, longId=201564, objectId=cda9201564f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cda9201564f8, replyNumber=0, likeNumber=0, createdTime=2021-04-11, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cda9201564f8, moduleTitle=Innate Immun：CD40上调树突状细胞与Th17/Treg失衡从而促进年轻人慢性牙周炎的骨丧失, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cda9201564f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864281, encodeId=155a1864281d2, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Nat Commun：双重阻断CD47和HER2能消除乳腺癌细胞的放疗抗性, objectType=article, longId=200793, objectId=70b2200e93d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70b2200e93d1, replyNumber=0, likeNumber=81, createdTime=2021-01-12, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70b2200e93d1, moduleTitle=Nat Commun：双重阻断CD47和HER2能消除乳腺癌细胞的放疗抗性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70b2200e93d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864278, encodeId=924218642e877, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Cell：大脑中存在CD4+T细胞，且影响大脑免疫“哨兵”的发育成熟, objectType=article, longId=198228, objectId=b07019822898, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b07019822898, replyNumber=0, likeNumber=83, createdTime=2020-12-20, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b07019822898, moduleTitle=Cell：大脑中存在CD4+T细胞，且影响大脑免疫“哨兵”的发育成熟, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b07019822898)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864275, encodeId=616318642e57c, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Antib Ther：CD47-SIRPα巨噬细胞免疫检查点通路靶点阻断的临床应用潜力, objectType=article, longId=193963, objectId=1660193963a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1660193963a8, replyNumber=0, likeNumber=90, createdTime=2020-07-20, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1660193963a8, moduleTitle=Antib Ther：CD47-SIRPα巨噬细胞免疫检查点通路靶点阻断的临床应用潜力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1660193963a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864290, encodeId=ecd0186429046, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=JAMA Netw Open： HIV患者血CD4+ T细胞计数和病毒载量是否与认知障碍风险相关?, objectType=article, longId=205849, objectId=8940205849f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8940205849f0, replyNumber=0, likeNumber=148, createdTime=2021-10-03, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8940205849f0, moduleTitle=JAMA Netw Open： HIV患者血CD4+ T细胞计数和病毒载量是否与认知障碍风险相关?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8940205849f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864289, encodeId=c4f9186428955, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Lancet Oncol：CD40激动性单克隆抗体APX005M联合化疗治疗转移性胰腺癌, objectType=article, longId=205427, objectId=c5f320542e03, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5f320542e03, replyNumber=0, likeNumber=79, createdTime=2021-05-04, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5f320542e03, moduleTitle=Lancet Oncol：CD40激动性单克隆抗体APX005M联合化疗治疗转移性胰腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5f320542e03)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864284, encodeId=d6191864284e7, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Histol Histopathol：慢性萎缩性胃炎可加重慢性牙周炎，伴有幽门螺杆菌感染和CD4+Th细胞因子浸润, objectType=article, longId=201565, objectId=d0a420156555, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0a420156555, replyNumber=0, likeNumber=102, createdTime=2021-08-14, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0a420156555, moduleTitle=Histol Histopathol：慢性萎缩性胃炎可加重慢性牙周炎，伴有幽门螺杆菌感染和CD4+Th细胞因子浸润, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0a420156555)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864291, encodeId=8ab6186429155, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=如何治疗PD-1难治性眼部黑色素瘤？抗CD40抗体YH003联合Toripalimab, objectType=article, longId=206768, objectId=a740206e6806, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a740206e6806, replyNumber=0, likeNumber=51, createdTime=2021-12-30, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a740206e6806, moduleTitle=如何治疗PD-1难治性眼部黑色素瘤？抗CD40抗体YH003联合Toripalimab, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a740206e6806)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864288, encodeId=e152186428876, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Blood：miR-29通过TRAF4调控CLL微环境中的CD40信号, objectType=article, longId=203914, objectId=125e20391447, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=125e20391447, replyNumber=0, likeNumber=67, createdTime=2021-02-02, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=125e20391447, moduleTitle=Blood：miR-29通过TRAF4调控CLL微环境中的CD40信号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=125e20391447)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864282, encodeId=b10a18642828f, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Circulation：动脉粥样硬化中的保护性CD4 T调节细胞的致病性转换, objectType=article, longId=201452, objectId=005f20145218, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=005f20145218, replyNumber=0, likeNumber=84, createdTime=2021-06-09, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=005f20145218, moduleTitle=Circulation：动脉粥样硬化中的保护性CD4 T调节细胞的致病性转换, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=005f20145218)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864269, encodeId=3e201864269f9, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=J Hepatology： HBV特异性CD4 T细胞的TNF-α/IFN-γ谱与慢性HBV感染中的肝损伤有关, objectType=article, longId=186943, objectId=5de218694321, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5de218694321, replyNumber=0, likeNumber=84, createdTime=2020-04-17, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5de218694321, moduleTitle=J Hepatology： HBV特异性CD4 T细胞的TNF-α/IFN-γ谱与慢性HBV感染中的肝损伤有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5de218694321)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864264, encodeId=fdaf18642645f, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=宜明昂科CD20/CD47双抗药物获批进入临床, objectType=article, longId=183838, objectId=4ac7183838c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ac7183838c5, replyNumber=0, likeNumber=99, createdTime=2020-08-04, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ac7183838c5, moduleTitle=宜明昂科CD20/CD47双抗药物获批进入临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ac7183838c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864265, encodeId=93201864265bd, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Int Arch Allergy Immunol：过敏性鼻炎患者中舌下和皮下免疫治疗CD4+CD25+FoxP3调控T细胞和血清细胞因子变化研究, objectType=article, longId=184406, objectId=653e18440667, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=653e18440667, replyNumber=0, likeNumber=93, createdTime=2020-09-06, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=653e18440667, moduleTitle=Int Arch Allergy Immunol：过敏性鼻炎患者中舌下和皮下免疫治疗CD4+CD25+FoxP3调控T细胞和血清细胞因子变化研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=653e18440667)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864279, encodeId=cbc618642e943, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=抗CD47 / PD-L1双特异性抗体临床试验：中国首例患者已入组, objectType=article, longId=198679, objectId=2c651986e9a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c651986e9a6, replyNumber=0, likeNumber=61, createdTime=2020-10-02, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c651986e9a6, moduleTitle=抗CD47 / PD-L1双特异性抗体临床试验：中国首例患者已入组, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c651986e9a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CD4

2020-05-29

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Blood：HCT后CD4+T细胞重建可预测急性GvHD患者的存活预后

2021-08-24

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Int Arch Allergy Immunol：间歇性过敏性鼻炎患者的血清CD48水平的提高

2021-01-09

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

宜明昂科CD47xHER2双特异性抗体获批临床，适应症为HER2表达的晚期实体瘤

2022-04-03

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

高瓴牵头砸进4亿美金，加持天境生物联手艾伯维开发明星靶点CD47

2021-03-07

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

思路迪医药获新一代CD47抗体新药大中华区**授权

2021-06-29

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

DCR：CD4/CD8比值可以作为HIV 阳性患者高级别肛门异型增生和肛门癌风险的新标志物

2021-09-13

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Innate Immun：CD40上调树突状细胞与Th17/Treg失衡从而促进年轻人慢性牙周炎的骨丧失

2021-04-11

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Nat Commun：双重阻断CD47和HER2能消除乳腺癌细胞的放疗抗性

2021-01-12

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Cell：大脑中存在CD4+T细胞，且影响大脑免疫“哨兵”的发育成熟

2020-12-20

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Antib Ther：CD47-SIRPα巨噬细胞免疫检查点通路靶点阻断的临床应用潜力

2020-07-20

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

JAMA Netw Open： HIV患者血CD4+ T细胞计数和病毒载量是否与认知障碍风险相关?

2021-10-03

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Lancet Oncol：CD40激动性单克隆抗体APX005M联合化疗治疗转移性胰腺癌

2021-05-04

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Histol Histopathol：慢性萎缩性胃炎可加重慢性牙周炎，伴有幽门螺杆菌感染和CD4+Th细胞因子浸润

2021-08-14

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

如何治疗PD-1难治性眼部黑色素瘤？抗CD40抗体YH003联合Toripalimab

2021-12-30

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Blood：miR-29通过TRAF4调控CLL微环境中的CD40信号

2021-02-02

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Circulation：动脉粥样硬化中的保护性CD4 T调节细胞的致病性转换

2021-06-09

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

J Hepatology： HBV特异性CD4 T细胞的TNF-α/IFN-γ谱与慢性HBV感染中的肝损伤有关

2020-04-17

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

宜明昂科CD20/CD47双抗药物获批进入临床

2020-08-04

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Int Arch Allergy Immunol：过敏性鼻炎患者中舌下和皮下免疫治疗CD4+CD25+FoxP3调控T细胞和血清细胞因子变化研究

2020-09-06

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

抗CD47 / PD-L1双特异性抗体临床试验：中国首例患者已入组

2020-10-02

科室
- - 订阅+
  - 更多科室
工具
服务